Sign In
Buy VKTX
$32.37
+1.99 (+6.55%)
At Close: Jun 22, 2026
Viking Therapeutics Shares Nosedive Toward Worst Day Ever After Obesity Trial Data
11:00am, Tuesday, 19'th Aug 2025
The once-daily pill VK2735 had lower weight-loss results on average compared to Eli Lilly's orforglipron, which was tested over 72 weeks. The highest dose of Eli Lilly's once-daily treatment helped pa
Viking Therapeutics shares fall more than 30% on disappointing obesity pill trial data
09:39am, Tuesday, 19'th Aug 2025
Shares of Viking Therapeutics fell more than 30% on Tuesday after the company released mid-stage trial data on its obesity pill that disappointed investors. While the weight loss caused by Viking's
Like Eli Lilly, Viking Therapeutics' Oral Weight Loss Drug Disappoints, Stock Tanks
09:28am, Tuesday, 19'th Aug 2025
On Tuesday, Viking Therapeutics Inc. VKTX released the much-awaited data from its Phase 2 trial of VK2735 pill, the company's dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent
Viking Therapeutics' stock tumbles after results of oral weight-loss drug trial. It has company.
09:11am, Tuesday, 19'th Aug 2025
Viking Therapeutics on Tuesday announced that a trial showed its oral weight-loss drug works — and like a larger rival, its stock price immediately suffered.
Viking Therapeutics stock tumbles 37% today, but here's why you should ‘HOLD'
08:57am, Tuesday, 19'th Aug 2025
Viking Therapeutics stock (NASDAQ: VKTX) plunged 37% in pre-market trading on Tuesday following the release of much-anticipated results from its mid-stage trial for the oral weight loss drug VK2735. T
Viking Therapeutics' oral weight-loss pill meets expectations in mid-stage study
07:18am, Tuesday, 19'th Aug 2025
Viking Therapeutics said on Tuesday its experimental weight-loss pill helped patients with obesity lose nearly 12.2% of their body weight on average over 13 weeks in a mid-stage study.
Study Achieves Primary and Secondary Endpoints, Demonstrating Statistically Significant Reductions in Body Weight with Once-Daily VK2735 Dosing as Compared to Placebo Up to 12.2% (26.6 lbs) Mean Weigh
Viking Therapeutics: Still On Track
08:56pm, Monday, 18'th Aug 2025
Viking Therapeutics offers a speculative opportunity, driven by its promising obesity drug pipeline and the massive potential of the GLP-1 market. Early clinical data for VK2735 is competitive, even o
Why Viking Therapeutics Stock Zoomed 5% Higher Today
06:18pm, Monday, 18'th Aug 2025
Good news from a peer and a positive analyst update were the elements driving Viking Therapeutics (VKTX 5.07%) stock higher on the first trading day of the week.
1 Beaten-Down Stock That Could Soar by the End of the Year
08:55am, Sunday, 17'th Aug 2025
Some smaller drugmakers choose to develop medicines for diseases for which there are no therapeutic options. This allows them to avoid direct competition from larger pharmaceutical companies.
The 3 Things That Matter for Viking Therapeutics Now
04:10am, Wednesday, 13'th Aug 2025
Investing successfully in biopharmaceutical companies can sometimes require complicated calculations worthy of Albert Einstein's brain. That's because picking the right ones involves a variation of th
Viking Therapeutics (VKTX) Is Considered a Good Investment by Brokers: Is That True?
10:31am, Monday, 04'th Aug 2025
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
This Biotech Stock Could Soar on Upcoming Clinical Data
07:15am, Monday, 04'th Aug 2025
While most investors pile into Eli Lilly (LLY 2.95%) or flee from struggling Novo Nordisk (NVO 2.48%), they're missing a compelling opportunity in the clinical-stage space. Novo recently lost nearly $
2 Beaten-Down Stocks With Incredible Upside Potential
12:32pm, Sunday, 03'rd Aug 2025
Recent history has, once again, demonstrated that relatively small biotech companies can see their shares soar significantly on positive developments. Summit Therapeutics' stock is up by more than 2,0
2 Biotech Stocks That Could Soar 29% and 165% According to Wall Street's Top Analysts
06:00am, Sunday, 03'rd Aug 2025
The healthcare industry has been a remarkable place for investors to build significant portfolio returns through the years. Companies that are providing life-saving medicines, devices, and other produ
